Concepedia

Marina Pesegova

MP

5

Publications

277

Citations

5

H-Index

2017

Active since

Affiliations

Krasnoyarsk Regional Clinical Hospital(Current)

Sheba Medical Center

Samsung Medical Center

Carol Davila University of Medicine and Pharmacy

Severance Hospital

Marina Pesegova is an author at Krasnoyarsk Regional Clinical Hospital specializing in medicine, gastroenterology, and immunology.

ORCID

Top concepts

Publications per year

2017–2019

5

Publications

5

Efficacy and safety of biosimilar CT-P13 compared with originator infliximab in patients with active Crohn's disease: an international, randomised, double-blind, phase 3 non-inferiority study

Byong Duk Ye, Marina Pesegova, Olga Alexeeva et al. · The Lancet · 2019 · 203 citations · Full text

, , +5

Budesonide Suppositories Are Effective and Safe for Treating Acute Ulcerative Proctitis

Wolfgang Kruis, Marina Pesegova, Oleksii Datsenko et al. · Clinical Gastroenterology and Hepatology · 2018 · 23 citations

814 - Phase Iii Randomized Controlled Trial to Compare Biosimilar Infliximab (CT-P13) with Innovator Infliximab in Patients with Active Crohn's Disease: 1-Year Maintenance and Switching Results

Byong Duk Ye, Young Ho Kim, Marina Pesegova et al. · Gastroenterology · 2018 · 20 citations

, , +7

DOP061 Phase III randomised, double-blind, controlled trial to compare biosimilar infliximab (CT-P13) with innovator infliximab in patients with active Crohn's disease: early efficacy and safety results

Yong‐Hwan Kim, B.D. Ye, Marina Pesegova et al. · Journal of Crohn s and Colitis · 2017 · 18 citations

, , +19

Phase III Randomized, Double-Blind, Controlled Trial to Compare Biosimilar Infliximab (CT-P13) with Innovator Infliximab (INX) in Patients with Active Crohn's Disease: Early Efficacy and Safety Results

Young Ho Kim, Byong Duk Ye, Marina Pesegova et al. · Gastroenterology · 2017 · 13 citations

, , +8

Rows per page

1–5 of 5